Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines
The recent 2009 pandemic H1N1 virus infection in humans has resulted in nearly 5,000 deaths worldwide. Early epidemiological findings indicated a low level of infection in the older population (>65 years) with the pandemic virus, and a greater susceptibility in people younger than 35 years of age, a phenomenon correlated with the presence of cross-reactive immunity in the older population. It is unclear what virus(es) might be responsible for this apparent cross-protection against the 2009 pandemic H1N1 virus. We describe a mouse lethal challenge model for the 2009 pandemic H1N1 strain, used together with a panel of inactivated H1N1 virus vaccines and hemagglutinin (HA) monoclonal antibodies to dissect the possible humoral antigenic determinants of pre-existing immunity against this virus in the human population. By hemagglutinination inhibition (HI) assays and vaccination/challenge studies, we demonstrate that the 2009 pandemic H1N1 virus is antigenically similar to human H1N1 viruses that circulated from 1918–1943 and to classical swine H1N1 viruses. Antibodies elicited against 1918-like or classical swine H1N1 vaccines completely protect C57B/6 mice from lethal challenge with the influenza A/Netherlands/602/2009 virus isolate. In contrast, contemporary H1N1 vaccines afforded only partial protection. Passive immunization with cross-reactive monoclonal antibodies (mAbs) raised against either 1918 or A/California/04/2009 HA proteins offered full protection from death. Analysis of mAb antibody escape mutants, generated by selection of 2009 H1N1 virus with these mAbs, indicate that antigenic site Sa is one of the conserved cross-protective epitopes. Our findings in mice agree with serological data showing high prevalence of 2009 H1N1 cross-reactive antibodies only in the older population, indicating that prior infection with 1918-like viruses or vaccination against the 1976 swine H1N1 virus in the USA are likely to provide protection against the 2009 pandemic H1N1 virus. This data provides a mechanistic basis for the protection seen in the older population, and emphasizes a rationale for including vaccination of the younger, naïve population. Our results also support the notion that pigs can act as an animal reservoir where influenza virus HAs become antigenically frozen for long periods of time, facilitating the generation of human pandemic viruses.
Vyšlo v časopise:
Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines. PLoS Pathog 6(1): e32767. doi:10.1371/journal.ppat.1000745
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000745
Souhrn
The recent 2009 pandemic H1N1 virus infection in humans has resulted in nearly 5,000 deaths worldwide. Early epidemiological findings indicated a low level of infection in the older population (>65 years) with the pandemic virus, and a greater susceptibility in people younger than 35 years of age, a phenomenon correlated with the presence of cross-reactive immunity in the older population. It is unclear what virus(es) might be responsible for this apparent cross-protection against the 2009 pandemic H1N1 virus. We describe a mouse lethal challenge model for the 2009 pandemic H1N1 strain, used together with a panel of inactivated H1N1 virus vaccines and hemagglutinin (HA) monoclonal antibodies to dissect the possible humoral antigenic determinants of pre-existing immunity against this virus in the human population. By hemagglutinination inhibition (HI) assays and vaccination/challenge studies, we demonstrate that the 2009 pandemic H1N1 virus is antigenically similar to human H1N1 viruses that circulated from 1918–1943 and to classical swine H1N1 viruses. Antibodies elicited against 1918-like or classical swine H1N1 vaccines completely protect C57B/6 mice from lethal challenge with the influenza A/Netherlands/602/2009 virus isolate. In contrast, contemporary H1N1 vaccines afforded only partial protection. Passive immunization with cross-reactive monoclonal antibodies (mAbs) raised against either 1918 or A/California/04/2009 HA proteins offered full protection from death. Analysis of mAb antibody escape mutants, generated by selection of 2009 H1N1 virus with these mAbs, indicate that antigenic site Sa is one of the conserved cross-protective epitopes. Our findings in mice agree with serological data showing high prevalence of 2009 H1N1 cross-reactive antibodies only in the older population, indicating that prior infection with 1918-like viruses or vaccination against the 1976 swine H1N1 virus in the USA are likely to provide protection against the 2009 pandemic H1N1 virus. This data provides a mechanistic basis for the protection seen in the older population, and emphasizes a rationale for including vaccination of the younger, naïve population. Our results also support the notion that pigs can act as an animal reservoir where influenza virus HAs become antigenically frozen for long periods of time, facilitating the generation of human pandemic viruses.
Zdroje
1. FioreAE
ShayDK
BroderK
IskanderJK
UyekiTM
2008 Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 57 1 60
2. PaleseP
ShawML
2007 Orthomyxoviridae: the viruses and their replication.
HowleyDMKPM
Fields virology. 5th edition Philadelphia, PA Lippincott Williams & Wilkins 1647 1689
3. CoxNJ
NeumannG
DonisRO
KawaokaY
2005 Orthomyxoviruses: influenza.
MahyBWJ
ter MeulenV
Topley and Wilson's microbiology and microbial infections London Hodder Arnold Press 634 698
4. Gillim-RossL
SubbaraoK
2006 Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev 19 614 636
5. SkehelJJ
WileyDC
2000 Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69 531 569
6. HorimotoT
KawaokaY
2005 Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3 591 600
7. MathewsJD
ChessonJM
McCawJM
McVernonJ
2009 Understanding influenza transmission, immunity and pandemic threats. Influenza Other Respi Viruses 3 143 149
8. NeumannG
KawaokaY
2006 Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis 12 881 886
9. WebsterRG
BeanWJ
GormanOT
ChambersTM
KawaokaY
1992 Evolution and ecology of influenza A viruses. Microbiol Rev 56 152 179
10. ScholtissekC
1994 Source for influenza pandemics. Eur J Epidemiol 10 455 458
11. TaubenbergerJK
MorensDM
2006 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 12 15 22
12. NelsonMI
ViboudC
SimonsenL
BennettRT
GriesemerSB
2008 Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog 4 e1000012 doi:10.1371/journal.ppat.1000012
13. VincentAL
MaW
LagerKM
JankeBH
RichtJA
2008 Swine influenza viruses a North American perspective. Adv Virus Res 72 127 154
14. NakajimaK
DesselbergerU
PaleseP
1978 Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature 274 334 339
15. ScholtissekC
von HoyningenV
RottR
1978 Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology 89 613 617
16. SencerDJ
MillarJD
2006 Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 12 29 33
17. GaydosJC
TopFHJr
HodderRA
RussellPK
2006 Swine influenza a outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 12 23 28
18. ShindeV
BridgesCB
UyekiTM
ShuB
BalishA
2009 Triple-reassortant swine influenza A (H1) in humans in the United States, 2005–2009. N Engl J Med 360 2616 2625
19. MyersKP
OlsenCW
GrayGC
2007 Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 44 1084 1088
20. DacsoCC
CouchRB
SixHR
YoungJF
QuarlesJM
1984 Sporadic occurrence of zoonotic swine influenza virus infections. J Clin Microbiol 20 833 835
21. WentworthDE
ThompsonBL
XuX
RegneryHL
CooleyAJ
1994 An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza. J Virol 68 2051 2058
22. DawoodFS
JainS
FinelliL
ShawMW
LindstromS
2009 Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360 2605 2615
23. ChowellG
BertozziSM
ColcheroMA
Lopez-GatellH
Alpuche-ArandaC
2009 Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361 674 679
24. 2009 Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009. MMWR Morb Mortal Wkly Rep 58 585 589
25. 2009 Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 84 185 189
26. PeirisJS
PoonLL
GuanY
2009 Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 45 169 173
27. HancockK
VeguillaV
LuX
ZhongW
ButlerEN
2009 Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361 1945 1952
28. ItohY
ShinyaK
KisoM
WatanabeT
SakodaY
2009 In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460 1021 1025
29. FodorE
DevenishL
EngelhardtOG
PaleseP
BrownleeGG
1999 Rescue of influenza A virus from recombinant DNA. J Virol 73 9679 9682
30. YuX
TsibaneT
McGrawPA
HouseFS
KeeferCJ
2008 Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455 532 536
31. SteelJ
LowenAC
PenaL
AngelM
SolorzanoA
2009 Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 83 1742 1753
32. CatonAJ
BrownleeGG
YewdellJW
GerhardW
1982 The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31 417 427
33. ReedMuench
1938 A simple method of estimating fitty per cent endpoints. The American Journal of Hygiene 27 493 497
34. ArnoldK
BordoliL
KoppJ
SchwedeT
2006 The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22 195 201
35. DeLanoWL
2002 The PyMOL Molecular Graphics System Palo Alto, CA, USA DeLano Scientific http://www.pymol.org
36. HoyleL
1968 The influenza viruses.
GardS
HallauerC
MeyerKF
New York Springer 170 171
37. BelsheRB
2009 Implications of the emergence of a novel H1 influenza virus. N Engl J Med 360 2667 2668
38. BaslerCF
AguilarPV
2008 Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. Antiviral Res 79 166 178
39. MunsterVJ
de WitE
van den BrandJM
HerfstS
SchrauwenEJ
2009 Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325 481 483
40. MainesTR
JayaramanA
BelserJA
WadfordDA
PappasC
2009 Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325 484 487
41. EnserinkM
2009 Pandemic influenza. Ferrets shed light on new virus's severity and spread. Science 325 17
42. BrownleeGG
FodorE
2001 The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci 356 1871 1876
43. TumpeyTM
Garcia-SastreA
TaubenbergerJK
PaleseP
SwayneDE
2004 Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A 101 3166 3171
44. SandbulteMR
JimenezGS
BoonAC
SmithLR
TreanorJJ
2007 Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4 e59 doi:10.1371/journal.pmed.0040059
45. PerroneLA
AhmadA
VeguillaV
LuX
SmithG
2009 Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 83 5726 5734
46. HensleySE
YewdellJW
2009 Que sera, sera: evolution of the swine H1N1 influenza A virus. Expert Rev Anti Infect Ther 7 763 768
47. BrightRA
CarterDM
DanilukS
ToapantaFR
AhmadA
2007 Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 25 3871 3878
48. RimmelzwaanGF
McElhaneyJE
2008 Correlates of protection: novel generations of influenza vaccines. Vaccine 26 Suppl 4 D41 44
49. GartenRJ
DavisCT
RussellCA
ShuB
LindstromS
2009 Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325 197 201
50. Van ReethK
GregoryV
HayA
PensaertM
2003 Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes. Vaccine 21 1375 1381
51. BikourMH
FrostEH
DeslandesS
TalbotB
ElazharyY
1995 Persistence of a 1930 swine influenza A (H1N1) virus in Quebec. J Gen Virol 76(Pt 10) 2539 2547
52. BikourMH
FrostEH
DeslandesS
TalbotB
WeberJM
1995 Recent H3N2 swine influenza virus with haemagglutinin and nucleoprotein genes similar to 1975 human strains. J Gen Virol 76(Pt 3) 697 703
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 1
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils
- CD8+ T Cell Control of HIV—A Known Unknown
- Polyoma Virus-Induced Osteosarcomas in Inbred Strains of Mice: Host Determinants of Metastasis
- The Deadly Chytrid Fungus: A Story of an Emerging Pathogen